If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Humalog® Therapies
Humalog® U-100 (insulin lispro injection)
100 units/mLHumalog® U-200 (insulin lispro injection)
200 units/mLHumalog® MIX50/50™ (50% insulin lispro protamine suspension 50% insulin lispro injection [rDNA origin])
100 units/mLHumalog® MIX75/25™ (75% insulin lispro protamine suspension 25% insulin lispro injection [rDNA origin])
100 units/mLThis information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Is dose adjustment needed when transitioning from another insulin to Humalog® (insulin lispro) 100 units/mL?
Dose adjustment may be needed when transitioning from another insulin to Humalog 100 units/mL.
Dose Adjustment
Dose adjustment may be needed when transitioning from another insulin to Humalog® (insulin lispro injection) 100 units/mL.1
The patient's glycemic control and predisposition to hypoglycemia or hyperglycemia may be affected by changes in insulin regimen such as
- insulin strength
- manufacturer
- type
- injection site, or
- method of administration.1
Any changes to insulin regimen for a patient with diabetes mellitus should be made cautiously and under close medical supervision and the frequency of blood glucose monitoring should be increased.1
Enclosed Prescribing Information
Reference
1Humalog [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.
Date of Last Review: July 04, 2022